4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-24-041437
Chief Financial Officer sold 5,446 shares at $32.12 ($174,926)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burrell Terry-Ann Chief Financial Officer | 2024-04-01 | Sale 10b5-1 | −5,446 | $32.12 | $174,926 | 70,137 | D |
| Open-market sales · 5,446 sh · avg $32.12 · $174,926 | |||||||
Loading xslF345X05/ownership.xml…